This inventor holds 14 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Neurological Disorders. Top assignees: Pharnext, Etex Building Performance International Sas, Lafarge Platres. Active years: 2012-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nimes, FR (2012 - 2018)
- Paris, FR (2014 - 2018)
- Nice, FR (2018 - 2022)
Company Filing History:
8 out of 54 
2 out of 7 
2 out of 31 
Years Active: 2012-2022
Areas of Expertise:
Title: Emmanuel Vial: Innovator in Pharmaceutical Compositions
Introduction
Emmanuel Vial is a prominent inventor based in Paris, France, known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, Vial has focused on developing innovative solutions for various medical conditions.
Latest Patents
Among his latest patents, Vial has developed compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema. This invention relates to a pharmaceutical composition that includes a compound of the avermectin family, preferably ivermectin, in a pharmaceutically acceptable carrier. It aims to provide effective treatment and prevention for individuals suffering from hand eczema. Additionally, Vial has created compositions for treating neurological disorders. This invention addresses neurological disorders related to glutamate excitotoxicity and Amyloid β toxicity. It specifically focuses on novel combinatorial therapies for conditions such as Multiple Sclerosis, Alzheimer's disease, Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, and spinal cord injury.
Career Highlights
Throughout his career, Emmanuel Vial has worked with notable companies, including Pharnext and Etex Building Performance International Sas. His work in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Vial has collaborated with esteemed colleagues, including Daniel Cohen and Ilya Chumakov. These partnerships have further enriched his research and innovation efforts in the pharmaceutical field.
Conclusion
Emmanuel Vial's work exemplifies the spirit of innovation in pharmaceuticals, particularly in addressing complex medical conditions. His contributions through patents and collaborations continue to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile